Zhang et al. demonstrated that the expression of H19 was significantly increased in breast cancer biopsies and plasma compared with healthy controls [30], plasma H19 levels were significantly correlated with progesterone and chemotherapy response [11]. The gene discussed is H19; the disease is breast carcinoma.